ExoAtlet

Completion of development and commercialization of innovative robotic platform - exoskeleton for rehabilitation and social adaptation

Commercialization of innovative robotic platform - exoskeleton for rehabilitation and social adaptation.

Results:

Exoskeleton sales began in 2016.
In October 2016, a joint venture ExoAtlet Asia Ltd was established in Korea (Company’s share is 35%), which has already sold 7 exoskeletons.
The company received NTI grant in the amount of 140 million rubles. and is currently developing to expand the product line.

World Exoskeleton Market Forecast, $ million

The company's revenue forecast, $ million

Clinical studies are conducted in collaboration with leading clinics in Russia and Korea:

$ Million financing

Competitive advantages of exoskeleton:

The exoathlet has enhanced capabilities of the control system and design: patient can change parameters of movement in the process of walking, voice control, walking with unloading of the feet, electro neuro muscle stimulation;
The design is easily disassembled by the patient, the weight of the structure is more than 20 kg;
Exoatlet is equipped with protection against injury when falling;

Mikhail Krundyshev

co-founder of the project, General Director

Ekaterina Bereziy

co-founder of the project, strategy development, optimization of business processes

Stepanov Andrey

Deputy Fund Director of the Project Development